At Swastika, you can get the Loan against securities (LAS) at low interest rate with repayment terms at your convenience.
When compared to other lender, the process of availing a loan from Swastika is simplified, with minimum documentation like PAN & Aadhaar card, photo, demat master and quick processing.
You can repay either in EMI’s or Fixed Period Loan/Overdraft with monthly interest payment or principal repayment upon sale of shares at your choice.
Once you submit all above documents, you can get money immediately in your account upon registration of pledge with your DP. And if you maintain your demat account with Swastika group you can get funds immediately.
Monthly interest will be included in Emi’s OR on actual use of funds in case of Fixed Period Loan/Overdraft facility.
Upto 60% of the current market value of shares, depends on category of shares.
In case of decrease in aggregate current market value of shares at any point of time, you have to refill the shortfall as per the standard funding ratio.
WHY CHOOSE US?
Your satisfaction matters the most to us. We don’t rest until you are happy. We are present from Kashmir to Kanyakumari, find us in more than 500 cities & towns.
To deliver quality service, we are a strong team of 804 highly experienced market experts
Our success has been recognised by NSE, BSE MCX, NCDEX, NSDL, CDSL and many more
Your satisfaction matters the most to us. We don’t rest until you are happy
Trade anytime, anywhere using our mobile app, website or desktop app.
Protect your demat account from cyber threats. Learn essential security measures, identify hacking signs, and follow step-by-step recovery process for 2025.
Discover the September 2025 IPOs – Glottis, Fabtech, Om Freight & Advance Agrolife. Learn which IPO could suit your portfolio and investment goals.
.png)
Detailed comparison of Trualt Bioenergy & Jinkushal Industries IPOs. Know key details, risks, valuation & outlook before investing.
.png)
Jain Resource, BMW Ventures & Epack Prefab IPOs hit the market! Get detailed analysis, financials, valuations & outlook. Apply or avoid?
